| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.001 |